Debarpan Dhar

Dr. Debarpan Dhar


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Bioactive Materials
Verified
Journal Article
Open access
TTTianjian Tong
Tianjian Tong
YQYijun Qi
Yijun Qi
DRDerrick Rollins
Derrick Rollins
LBLuke Bussiere
Luke Bussiere
DDDebarpan Dhar
Debarpan Dhar
Qun WangQun Wang
Qun Wang
Effective oral drugs and vaccines require high delivery efficiency across the gastrointestinal epithelia and protection of medically effective payloads (i.e., immunogens) against gastric damage. In this study, hollowed nanocarriers (NCs: silica nanospheres and gold nanocages) with poly-l-lysine (PLL) coating and mammalian orthoreovirus cell attachment protein σ1 functionalization (NC-PLL-σ1) were explored as functional oral drug delivery vehicles (ODDVs). The transport of these ODDVs to mucosal lymphoid tissues could be facilitated by microfold cells (M-cells) mediated transcytosis (via σ1-α2–3-linked sialic acids adherence) across gastrointestinal epithelia. PLL coating provided protection and slow-release of rhodamine 6 G (R6G), a model payload. The transport effectiveness of these ODDVs was tested on intestinal organoid monolayers in vitro. When compared with other experimental groups, the fully functionalized ODDV system (with PLL-σ1) demonstrated two significant advantages: a significantly higher transport efficiency (198% over blank control at 48 h); and protection of payloads which led to both better transport efficiency and extended-release of payloads (61% over uncoated carriers at 48 h). In addition, it was shown that the M cell presence in intestinal organoid monolayers (modulated by Rank L stimulation) was a determining factor on the transport efficiency of the ODDVs: more M-cells (induced by higher Rank L) in the organoid monolayers led to higher transport efficiency for ODDV-delivered model payload (R6G). The fully functionalized ODDVs showed great potential as effective oral delivery vehicles for drugs and vaccines.

1 May 2018 in Microbiology
Verified
Journal Article
Closed access
RCRhishita Chourashi
Rhishita Chourashi
SDSuman Das
Suman Das
DDDebarpan Dhar
Debarpan Dhar
KOKeinosuke Okamoto
Keinosuke Okamoto
AMAsish K. Mukhopadhyay
Asish K. Mukhopadhyay
NCNabendu Sekhar Chatterjee
Nabendu Sekhar Chatterjee
Vibrio cholerae regularly colonizes the chitinous exoskeleton of crustacean shells in the aquatic region. The type 6 secretion system (T6SS) in V. cholerae is an interbacterial killing device. This system is thought to provide a competitive advantage to V. cholerae in a polymicrobial community of the aquatic region under nutrient-poor conditions. V. cholerae chitin sensing is known to be initiated by the activation of a two-component sensor histidine kinase ChiS in the presence of GlcNAc2 (N,N′-diacetylchitobiose) residues generated by the action of chitinases on chitin. It is known that T6SS in V. cholerae is generally induced by chitin. However, the effect of ChiS activation on T6SS is unknown. Here, we found that ChiS inactivation resulted in impaired bacterial killing and reduced expression of T6SS genes. Active ChiS positively affected T6SS-mediated natural transformation in V. cholerae. ChiS depletion or inactivation also resulted in reduced colonization on insoluble chitin surfaces. Therefore, we have shown that V. cholerae colonization on chitinous surfaces activates ChiS, which promotes T6SS-dependent bacterial killing and horizontal gene transfer. We also highlight the importance of chitinases in T6SS upregulation.

15 July 2025 in Journal of Clinical Virology
Verified
Journal Article
Closed access
DDDebarpan Dhar
Debarpan Dhar
ASAnjana Sasidharan
Anjana Sasidharan
KVKatelyn E. VanDonge
Katelyn E. VanDonge
BLBrian Lee
Brian Lee
MDMaria Deza-Leon
Maria Deza-Leon
RSRangaraj Selvarangan
Rangaraj Selvarangan

Verified
Journal Article
Open access
PDF file
DDDebarpan Dhar
Debarpan Dhar
TNTerry Fei Fan Ng
Terry Fei Fan Ng
CHChristopher J Harrison
Christopher J Harrison
EREric Rhoden
Eric Rhoden
BMBernardo Mainou
Bernardo Mainou
RSRangaraj Selvarangan
Rangaraj Selvarangan
We report the complete genome sequences of four parechovirus-A3 (PeV-A3) isolates from Children’s Mercy Kansas City (CMKC), United States of America (USA): PeV-A3-MO-12-CMKC/CSF/MO/USA/2012 (isolated in 2012 from cerebrospinal fluid), PeV-A3-8C-CMKC/CSF/MO/USA/2022/ (isolated in 2022 from cerebrospinal fluid), PeV-A3-9C-CMKC/CSF/MO/USA/2022 (isolated in 2022 from cerebrospinal fluid), and PeV-A3-11B-CMKC/Blood/MO/USA/2022 (isolated in 2022 from blood). Sequence analysis revealed multiple mutations throughout the genome of the PeV-A3 isolates in comparison to the prototypic PeV-A3 A308/99 reference sequence (AB084913). Several unique amino acid changes were observed in the PeV-A3 isolates from 2022 that were absent in the PeV-A3 isolate from 2012. Phylogenetic analysis comparison determined that the sequenced PeV-A3 isolates from 2022 cluster together as a separate clade.